Skip to main content
Have a personal or library account? Click to login
Green-Synthesized ZnO Nanoparticles from Arum rupicola: Antibacterial and Antibiofilm Activity Against MDR Pathogens with Cytotoxicity Insights Cover

Green-Synthesized ZnO Nanoparticles from Arum rupicola: Antibacterial and Antibiofilm Activity Against MDR Pathogens with Cytotoxicity Insights

Open Access
|Sep 2026
Read online

Figures & tables

Fig. 1.

Collection site of ARVR on Betwata Mountain near Ranya, Kurdistan Region, Iraq. The red marker indicates the sampling location (36°19′18.43″ N, 44°56′48.61″ E). Elevation is shown in meters, with darker shades representing higher altitudes.

Fig. 2.

Diagrammatic illustration of the biofabrication process of ZnO-NPs. (A) ARVR specimen. (B) Dried leaf powder. (C) Aqueous extract. (D) Zn(NO3)2·6H2O solution. (E and F) ZnO-NPs after 2 h of stirring and heating at 60 ± 3°C with plant extract. (G) ZnO-NPs before calcination. (H) ZnO-NPs after calcination in a muffle furnace.

Fig. 3.

Gas chromatography–mass spectrometry (GC–MS) chromatogram of the aqueous leaf extract of Arum rupicola var. rupicola (ARVR). The chromatogram shows the distribution of metabolites detected in the extract, including phenolic compounds, oxygenated metabolites, fatty acids, fatty acid esters, and other phytochemical constituents. A total of 56 compounds were identified based on retention time and mass spectral matching.

Table I

List of chemical compounds identified in the plant extract by GC–MS analysis, including compound names, retention times, and relative peak area percentages.

No.Chemical compoundsArea %R.T.
1Methyl 2-hydroxy-2-methoxyacetate1.10384.315
2Butanal, 3-methyl-0.73774.716
31,2-Pentanediol0.5644.951
42-Propanamine, N-methyl-N-nitroso-0.27785.572
5Pyrazine, methyl-0.77316.507
6Dimethyl Sulfoxide3.30086.703
7Dimethyl Sulfoxide0.2717.426
81,5-Pentanedithiol0.25157.819
9Acetaldehyde, ethylidenehydrazone0.62767.999
10Pyrazine, 2,5-dimethyl-1.28088.486
112-Dodecylcyclobutanone0.568.793
12N-(2-Methylbutylidene)isobutylami0.62019.005
132-Furanmethanol, 5-methyl-0.19269.476
141,7-Diazabicyclo[2.2.0]heptane0.17449.712
152,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one1.06649.94
16Decane1.251410.183
17Propanenitrile, 3,3’-iminobis-1.925510.474
182-[(2-Oxocycloheptyl)methyl]cycloheptan-1-one (isomer 2)0.271510.694
192-Butenal, 3-methyl-0.650210.914
20Benzeneacetaldehyde0.397811.251
21Furaneol0.510511.487
221-Ethyl-2-pyrrolidinone0.911211.77
23But-3-enyl (E)-2-methylbut-2-enoate2.156512.155
24cis-1-Butene,1-butoxy-0.258712.65
254H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-3.300212.972
26Benzoic acid0.214813.364
272-Pyrrolidinone, 5-(hydroxymethyl)-3.219313.561
28Benzofuran, 2,3-dihydro-2.300314.103
29Decanoic acid, 3-hydroxy-, methyl ester1.142214.456
302,4-Difluoroanisole1.755315.053
312-Methoxy-4-vinylphenol1.077815.54
32Butanoic acid, 3-methyl-, hexyl ester0.388415.807
33DL-Proline, 5-oxo-, methyl ester1.110616.365
341,2,4-Benzenetriol0.548916.695
35trans-Cinnamic acid0.502316.986
364-Vinylbenzene-1,2-diol1.333917.221
37N,N-Diamylmethylamine0.3717.677
382-Hydroxy-1-(1’-pyrrolidiyl)-1-buten-3-one1.593118.211
392(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (R)-0.442818.502
40Phenol, 4-ethenyl-2,6-dimethoxy-1.113818.769
413-Methyl-4-phenyl-1H-pyrrole1.747119.005
42Octahydropyrrolo[1,2-a]pyrazine0.356619.256
431,3-Benzenediol, 4,5-dimethyl-0.392620.206
44Tetradecanoic acid0.368620.819
452(1H)-Pyridinone, 1,3,6-trimethyl-0.916621
46Phthalic acid, isobutyl undecyl ester0.441222.068
47Hexadecanoic acid, methyl ester4.366122.539
48n-Hexadecanoic acid9.670822.893
499-Octadecenoic acid, methyl ester, (E)-11.776724.228
50Methyl stearate4.011724.44
519,12,15-Octadecatrienoic acid, (Z,Z,Z)-16.438224.613
52Methyl 9-cis,11-trans-octadecadienoate1.96324.998
533’-O-Acetylthymidine0.550226.483
543-Eicosene, (E)-1.556127.496
55Bis(2-ethylhexyl) phthalate1.08728.015
561-Tetracosene3.80929.02
Fig. 4.

Quantitative phytochemical analysis of ARVR leaf extract showing total phenolic content, antioxidant capacity, and total flavonoid content, expressed as mg/g fresh weight (FW). Data are presented as mean ± standard deviation (SD) from three independent biological replicates.

Table II

MDR profiles of the studied bacterial isolates. Antibiotic susceptibility was determined using the BD Phoenix system and interpreted according to CLSI M100 (34th edition, 2024) (Clinical & Laboratory Standards 2024).

Bacterial strainResistant antibiotics (class)Number of antibiotics classes
Staphylococcus aureusGentamicin (Aminoglycoside); Penicillin, Oxacillin, Cefoxitin (β-lactams); Erythromycin (Macrolide); Clindamycin (Lincosamide); Ciprofloxacin, Levofloxacin (Fluoroquinolones)5
Staphylococcus epidermidisGentamicin (Aminoglycoside); Penicillin, Oxacillin, Cefoxitin (β-lactams); Erythromycin (Macrolide); Clindamycin (Lincosamide); Ciprofloxacin, Levofloxacin (Fluoroquinolones)5
Escherichia coliGentamicin, Amikacin (Aminoglycosides); Ampicillin, Cefotaxime, Ceftazidime, Cefazolin (β-lactams); Imipenem, Ertapenem, Meropenem (Carbapenems); Ciprofloxacin, Levofloxacin (Fluoroquinolones); Trimethoprim–sulfamethoxazole (Sulfonamide)5
Klebsiella aerogenesGentamicin, Amikacin (Aminoglycosides); Ampicillin, Cefazolin, Cefuroxime, Ceftazidime (β-lactams); Ciprofloxacin, Levofloxacin (Fluoroquinolones); Trimethoprim–sulfamethoxazole (Sulfonamide)4
Fig. 5.

Phylogenetic tree of S. epidermidis Charmo3, S. aureus Charmo4, E. coli Charmo5, and K. aerogenes Charmo28 based on 16S rRNA gene sequences. DNA sequences were aligned using ClustalX, and the tree was constructed in MEGA 11 with the neighbor-joining method and 1,000 bootstrap replicates. Bootstrap values are shown at branch nodes.

The scale bar represents 0.01 nucleotide substitutions per site.

Fig. 6.

UV–Vis absorption spectrum of biosynthesized ZnO-NPs using ARVR leaf extract, showing a characteristic band-edge peak at 383 nm.

Fig. 7.

X-ray diffraction (XRD) pattern of biosynthesized ZnO-NPs (pH 8.0, calcined at 430°C for 2 h). The diffraction peaks at 2θ = 31.8°, 34.5°, 36.2°, 47.6°, 56.6°, 62.9°, and 68.2° correspond to the (100), (002), (101), (102), (110), (103), and (200) planes of hexagonal wurtzite ZnO, in agreement with the JCPDS standard (card no. 04-003-2106) (Kisi & Elcombe, 1989), confirming high crystallinity and phase purity.

Fig. 8.

FTIR spectra of the ARVR plant leaf extract and the biosynthesized ZnO nanoparticles (ZnO-NPs). The spectra display characteristic absorption bands corresponding to O–H, C–H, C=O, N–H, C–N, and C–O functional groups, highlighting the role of phytochemicals in ZnO-NP formation and stabilization. The distinct band observed at ~526 cm−1 confirms Zn–O stretching vibrations.

Fig. 9.

Energy-dispersive X-ray spectroscopy (EDS) spectrum of biosynthesized ZnO-NPs. Strong peaks for zinc (Zn) and oxygen (O) confirm ZnO formation, with Zn (62.12 wt%) as the dominant element and O (28.64 wt%).

A minor phosphorus (P) peak was also detected, likely originating from phytochemicals in the plant extract.

Fig. 10.

(A) DLS analysis showing a Z-average hydrodynamic diameter of ~80 nm and a moderate polydispersity index (PDI) of 0.36, measured in triplicate. (B) Zeta potential of ZnO-NPs in aqueous solution at 25 °C, showing a negative charge of −28.3± 0.286 mV (triplicate readings), indicating good colloidal stability.

Fig. 11.

SEM images of biosynthesized ZnO-NPs showing predominantly spherical particles with occasional flower-like aggregates. Scale bars: 500 nm (A) and 200 nm (B).

Fig. 12.

A: Representative TEM image showing aggregated but nearly spherical nanoparticles (scale bar = 100 nm). B: Particle size distribution histogram with Gaussian fitting, indicating a size range of 20–35 nm and an average diameter of ~27.7 ± 3.9 nm.

Table III

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of ARVR-derived ZnO-NPs against clinical isolates. Values are expressed as mean ± SD (μg/ml, n = 3).

Bacterial IsolatesMIC (µg/ml)MBC (µg/ml)
Staphylococcus epidermidis Charmo3156 ± 20312 ± 10
Klebsiella aerogenes Charmo28156 ± 10312 ± 20
Staphylococcus aureus Charmo4312 ± 10625 ± 15
Escheirchia coli Charmo5312 ± 10625 ± 10
Fig. 13.

Dose-dependent antibiofilm activity of ARVR-derived ZnO-NPs against Staphylococcus epidermidis Charmo3, Staphylococcus aureus Charmo4, Escherichia coli Charmo5, and Klebsiella aerogenes Charmo28. Biofilm inhibition was quantified after 24 h of exposure to increasing ZnO-NPs concentrations (4.8–156 μg/ml). Data are expressed as mean ± SD from three independent biological replicates.

Fig. 14.

Cytotoxic and morphological effects of ZnO-NPs on HEK-293 cells. (A) Cell viability (%) after 24 h exposure to ZnO-NPs (0–1000 μg/ml), determined by MTT assay and expressed relative to control (100%). Data represent mean ± SD (n = 3).

Different letters indicate significant differences (p < 0.05; one-way ANOVA with Tukey’s post hoc test).

The IC50 value was 16.67 μg/ml. (B) Representative images of HEK-293 cells after 24 h treatment showing concentration-dependent morphological changes, including reduced cell density and cell shrinkage compared to control.

DOI: https://doi.org/10.33073/pjm-2026-027 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 319 - 342
Submitted on: May 26, 2026
Accepted on: Jun 23, 2026
Published on: Sep 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Pyman M. Mohamedsalih, Dana Khdr Sabir, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.